quantisnow
FeedTopReportsPricing
⌘K
Live feed
09:00:28·337d
SECFiling
Petros Pharmaceuticals Inc. logo

Petros Pharmaceuticals Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

PTPI· Petros Pharmaceuticals Inc.
Health Care
Original source

Companies

  • PTPI
    Petros Pharmaceuticals Inc.
    Health Care

Related

  • SEC8d
    SEC Form 10-K filed by Petros Pharmaceuticals Inc.
  • SEC23d
    SEC Form NT 10-K filed by Petros Pharmaceuticals Inc.
  • SEC65d
    Amendment: SEC Form SCHEDULE 13G/A filed by Petros Pharmaceuticals Inc.
  • INSIDER107d
    Officer Boctor Fady was granted 500,000 shares, increasing direct ownership by 2,502% to 519,986 units (SEC Form 4)
  • INSIDER111d
    Director Silverman Joshua was granted 4,375,000 shares, increasing direct ownership by 10,816% to 4,415,450 units (SEC Form 4)
  • INSIDER111d
    Director Walker Wayne Remell was granted 500,000 shares, increasing direct ownership by 7,895% to 506,333 units (SEC Form 4)
  • SEC111d
    Petros Pharmaceuticals Inc. filed SEC Form 8-K: Leadership Update
  • INSIDER111d
    Director Bernstein Bruce was granted 1,875,000 shares, increasing direct ownership by 15,202% to 1,887,334 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022